Stocksigma LogoStocksigma Logo

Fischer Medical Board Approves ₹50 Crore Total Investment in Wholly Owned Subsidiaries

Fischer Medical Ventures' board approved investments totaling ₹50.00 Cr via rights issues across three material wholly owned subsidiaries on 24th Sep'26

Fischer Medical Board Approves ₹50 Crore Total Investment in Wholly Owned Subsidiaries

Fischer Medical Ventures Ltd · Outcome · 25 Sept 2026, 4:50 pm

Fischer Medical Board Approves ₹50 Crore Total Investment in Wholly Owned Subsidiaries Fischer Medical Ventures' board approved investments totaling ₹50.00 Cr via rights issues across three material wholly owned subsidiaries on 24th Sep'26. The capital deployment comprises ₹11.50 Cr for 15,603 shares in Time Medical International Ventures (India) at ₹7,370.25 each, ₹12.50 Cr for 1,507 shares in Flynncare Health Innovations at ₹82,943.48 each, and ₹26.00 Cr for 53 shares in Singapore-based FMV Global Innovation Pte. Ltd. at ₹48,83,552.64 each. All transactions are done on an arm's-length cash basis, maintaining 100% ownership across the entities.

Original exchange filing (PDF)

More announcements from Fischer Medical Ventures Ltd

All Fischer Medical Ventures Ltd announcements